Global Translational Regenerative Medicine Market Research Report 2022

Due to the COVID-19 pandemic, the global Translational Regenerative Medicine market size is estimated to be worth US$ 12230 million in 2021 and is forecast to a readjusted size of US$ 30580 million by 2028 with a CAGR of 13.5% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Translational Regenerative Medicine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Translational Regenerative Medicine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Stem Cell Therapy accounting for % of the Translational Regenerative Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Tissue Engineering Therapy segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Translational Regenerative Medicine include Athersys, Avita Medical, AxoGen, MEDIPOST, NuVasive, Astellas Pharma, Organogenesis Holdings, Osiris Therapeutics and Pharmicell, etc. In terms of revenue, the global 3 largest players have a % market share of Translational Regenerative Medicine in 2021.
This report focuses on Translational Regenerative Medicine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Translational Regenerative Medicine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Translational Regenerative Medicine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Stem Cell Therapy
Tissue Engineering
Gene Therapy
Segment by Application
Tissue Engineering Therapy
Wound Healing
Cartilage Repair
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Athersys
Avita Medical
AxoGen
MEDIPOST
NuVasive
Astellas Pharma
Organogenesis Holdings
Osiris Therapeutics
Pharmicell
Regenerys
Takeda Pharmaceutical
uniQure
Vericel

Frequently Asked Questions